Back to WA Wealthspire Advisors, LLC

CPRXCPRX
Showing 8 of 26 quarters

Position history for WAWealthspire Advisors, LLC's holdings in CATALYST PHARMACEUTICALS INC

Wealthspire Advisors, LLC holds 18,142 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $570,204 as of 2026-Q2. The position was decreased (-47.2% shares). CPRX represents 0.0% of Wealthspire Advisors, LLC's portfolio.

Current Value

$570,204

Current Shares

18,142

Total Value Change

-$111,104

Total Shares Change

-16,129

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
18,142
-47.2%
$570,2040.0%$31.43
0
2026-Q1
Decreased
34,359
-7.5%
$850,7290.0%$23.92
0
2025-Q4
Increased
37,160
+0.9%
$867,3150.0%$23.29
25
2025-Q3
Decreased
36,843
-0.1%
$725,8070.0%$19.55
0
2025-Q2
Increased
36,879
+7.1%
$800,2750.0%$21.78
27
2025-Q1
Increased
34,434
+0.2%
$835,0250.0%$24.69
25
2024-Q4
Increased
34,355
+0.3%
$716,9890.0%$21.07
25
2024-Q3
Decreased
34,271
-5.6%
$681,3080.0%$19.56
0

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used